HomepageHLUN-A • CPH
add
H Lundbeck A/S Class A
Vorige slotkoers
kr 29,05
Dag-range
kr 29,05 - kr 30,70
Jaar-range
kr 23,30 - kr 41,70
Beurswaarde
34,54Â mld. DKK
Gem. volume
119,00K
Koers/winst
-
Dividendrendement
-
Primaire beurs
CPH
Marktnieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
(DKK) | mrt 2025info | Wijziging j-o-j |
---|---|---|
Opbrengst | 6,24Â mld. | 17,91% |
Bedrijfskosten | 3,45Â mld. | 15,06% |
Netto inkomsten | 1,15Â mld. | 14,51% |
Netto winstmarge | 18,48 | -2,84% |
Winst per aandeel | 1,53 | 10,87% |
EBITDA | 2,14Â mld. | 22,79% |
Effectief belastingtarief | 22,00% | — |
Balans
Totale activa
Totale passiva
(DKK) | mrt 2025info | Wijziging j-o-j |
---|---|---|
Contanten en kortetermijnbeleggingen | 2,70Â mld. | -47,25% |
Totale activa | 54,22Â mld. | 43,24% |
Totale passiva | 29,65Â mld. | 92,31% |
Totaal aandelenvermogen | 24,57 mld. | — |
Uitstaande aandelen | 991,90 mln. | — |
Koers-boekwaardeverhouding | 1,17 | — |
Rendement op activa | 7,64% | — |
Rendement op kapitaal | 10,42% | — |
Kasstroom
Nettomutatie in liquide middelen
(DKK) | mrt 2025info | Wijziging j-o-j |
---|---|---|
Netto inkomsten | 1,15Â mld. | 14,51% |
Operationele kasstroom | 632,00Â mln. | -34,24% |
Kasstroom uit beleggingen | -111,00Â mln. | -18,09% |
Kasstroom uit financiering | -2,48Â mld. | -226,32% |
Nettomutatie in liquide middelen | -1,97Â mld. | -2.009,71% |
Vrije kasstroom | -544,88Â mln. | -180,75% |
Over
H. Lundbeck A/S, commonly referred to as Lundbeck, is a Danish international pharmaceutical company engaged in the research, development, manufacturing, marketing and sale of pharmaceuticals across the world. The company’s products are targeted at brain diseases, including depression, schizophrenia, Alzheimer's disease, Parkinson's disease and migraine.
Headquartered in Copenhagen, Denmark, Lundbeck has approximately 5,600 employees in more than 50 countries, and their products are registered in more than 100 countries. They have production facilities in Denmark, France and Italy and their research centers are based in Denmark and the US.
Lundbeck is listed on the Copenhagen Stock Exchange.
Lundbeck is a full member of the European Federation of Pharmaceutical Industries and Associations and of the International Federation of Pharmaceutical Manufacturers and Associations Wikipedia
Opgericht
14 aug 1915
Website
Werknemers
5.700